Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Estee Lauder Companies Cl A / Equity Bottom-Up

The Estee Lauder Companies Inc. manufactures and markets a wide range of skin care, makeup, fragrance, and hair care products.  The Company's products are sold in countries and territories around the world.

<ul><li>The third-quarter fiscal results of The Estée Lauder Companies showcased a strong performance, marked by an inflection point demonstrating a renewed sales and profit growth trajectory.</li><li>The top-line numbers saw an organic sales growth of 6%, thereby meeting the firm's high range outlook.</li><li>The company also reported exceeding expectations in terms of profitability and improving working capital significantly.</li></ul>

The third-quarter fiscal results of The Estée Lauder Companies showcased a strong performance, marked by an inflection point demonstrating a renewed sales and profit growth trajectory.The top-line numbers saw an organic sales growth of 6%, thereby meeting the firm's high range outlook.The company also reported exceeding expectations in terms of profitability and improving working capital significantly.

The Estée Lauder Companies: What Is Their  Profit Recovery Plan For Sales Growth & Profitability? - Major Drivers

Yum! Brands, Inc, owns and franchises quick-service restaurants worldwide.  The Company develops, operates, franchises and licenses a worldwide system of restaurants which prepare, package and sell a menu of food items.

<ul><li>Yum!</li><li>Brands, Inc.'s Q1 2024 Earnings highlighted a mixed performance, demonstrating the resilience of the business amidst a challenging operating environment.</li><li>The company saw a growth rate of 6% in its core operating profit this quarter.</li></ul>

Yum!Brands, Inc.'s Q1 2024 Earnings highlighted a mixed performance, demonstrating the resilience of the business amidst a challenging operating environment.The company saw a growth rate of 6% in its core operating profit this quarter.

Yum! Brands Inc.: How Is Their Global Expansion of Franchise Locations Going? - Major Drivers

The Kraft Heinz Company provides food services. The Company offers foods including ketchup, sauces, meals, snacks, and other food products.

<ul><li>Kraft Heinz Co.'s Q1 2024 earnings call highlighted strong areas but also pointed towards potential challenges the company may face, leading to a potential balanced investment thesis.</li><li>The company emphasized their strategic positioning to serve all consumers regardless of income, be it low earners looking for value as they prepare more meals at home or higher earners seeking culinary delights as they venture into leisure activities.</li><li>The company believes its edge stems from three factors: bringing innovative food solutions quicker than ever; renovating their existing brands to adapt to modern trends; and having what they believe to be the best team in the industry.</li></ul>

Kraft Heinz Co.'s Q1 2024 earnings call highlighted strong areas but also pointed towards potential challenges the company may face, leading to a potential balanced investment thesis.The company emphasized their strategic positioning to serve all consumers regardless of income, be it low earners looking for value as they prepare more meals at home or higher earners seeking culinary delights as they venture into leisure activities.The company believes its edge stems from three factors: bringing innovative food solutions quicker than ever; renovating their existing brands to adapt to modern trends; and having what they believe to be the best team in the industry.

The Kraft Heinz Company:  Expansion in Away-From-Home and Emerging Markets & Other Critical Growth Drivers

Martin Marietta Materials / Equity Bottom-Up

Martin Marietta Materials, Inc. produces aggregates for the construction industry, including highways, infrastructure, commercial, and residential. The Company also manufactures and markets magnesia-based products, including heat-resistant refractory products for the steel industry, chemical products for industrial and environmental uses, and dolomitic lime.

<ul><li>The Q1 2024 earnings for Martin Marietta showed some level of optimism for the company's growth prospects, though the transcript also raises some potential concerns.</li><li>Mr.</li><li>Ward Nye, the CEO, highlighted various positive aspects including steady product demand, favorable commercial dynamics, and recent transactions aimed at optimizing the company's portfolio.</li></ul>

The Q1 2024 earnings for Martin Marietta showed some level of optimism for the company's growth prospects, though the transcript also raises some potential concerns.Mr.Ward Nye, the CEO, highlighted various positive aspects including steady product demand, favorable commercial dynamics, and recent transactions aimed at optimizing the company's portfolio.

Martin Marietta Materials:  Growth Prospects Amidst U.S. Infrastructure Spending Surge! - Major Drivers

GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GSK provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

<ul><li>GlaxoSmithKline demonstrated robust quarterly performance, continuing its commitment to creating long-term value for its stakeholders.</li><li>The company managed to deliver double-digit growth for the quarter, with sales increasing by 13% to GBP 7.4 billion, core operating profit going up by 35% to GBP 2.4 billion, and core earnings per share increasing by 37%.</li><li>Underpinning GlaxoSmithKline's solid financial results is the successful launch and strong delivery of its new products, reflecting the company's ability to continue growing and innovating in the highly competitive pharmaceutical industry.</li></ul>

GlaxoSmithKline demonstrated robust quarterly performance, continuing its commitment to creating long-term value for its stakeholders.The company managed to deliver double-digit growth for the quarter, with sales increasing by 13% to GBP 7.4 billion, core operating profit going up by 35% to GBP 2.4 billion, and core earnings per share increasing by 37%.Underpinning GlaxoSmithKline's solid financial results is the successful launch and strong delivery of its new products, reflecting the company's ability to continue growing and innovating in the highly competitive pharmaceutical industry.

GlaxoSmithKline plc: Will Its  Ongoing Investment In Oncology & Vaccines Pay Off? - Major Drivers

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.